Published in Mol Med on October 19, 2006
Translational systems biology of inflammation. PLoS Comput Biol (2008) 2.15
A two-compartment mathematical model of endotoxin-induced inflammatory and physiologic alterations in swine. Crit Care Med (2012) 1.69
Mechanistic simulations of inflammation: current state and future prospects. Math Biosci (2008) 1.40
A patient-specific in silico model of inflammation and healing tested in acute vocal fold injury. PLoS One (2008) 1.38
Sepsis: Something old, something new, and a systems view. J Crit Care (2011) 1.29
A dynamic view of trauma/hemorrhage-induced inflammation in mice: principal drivers and networks. PLoS One (2011) 1.24
Translational systems approaches to the biology of inflammation and healing. Immunopharmacol Immunotoxicol (2010) 1.18
Translational systems biology: introduction of an engineering approach to the pathophysiology of the burn patient. J Burn Care Res (2008) 1.17
Modeling endotoxin-induced systemic inflammation using an indirect response approach. Math Biosci (2008) 1.13
In silico modeling: methods and applications to trauma and sepsis. Crit Care Med (2013) 1.12
A mathematical simulation of the inflammatory response to anthrax infection. Shock (2008) 1.11
The acute inflammatory response in trauma / hemorrhage and traumatic brain injury: current state and emerging prospects. Libyan J Med (2009) 1.08
A systems model for immune cell interactions unravels the mechanism of inflammation in human skin. PLoS Comput Biol (2010) 1.07
In silico simulation of corticosteroids effect on an NFkB- dependent physicochemical model of systemic inflammation. PLoS One (2009) 1.04
Translational systems biology of inflammation and healing. Wound Repair Regen (2010) 1.02
Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2. Ann Surg (2007) 1.01
Evidence-based modeling of critical illness: an initial consensus from the Society for Complexity in Acute Illness. J Crit Care (2007) 1.01
Challenges and rewards on the road to translational systems biology in acute illness: four case reports from interdisciplinary teams. J Crit Care (2007) 1.00
Central role for MCP-1/CCL2 in injury-induced inflammation revealed by in vitro, in silico, and clinical studies. PLoS One (2013) 0.98
An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Math Biosci (2011) 0.98
Linking Inflammation, Cardiorespiratory Variability, and Neural Control in Acute Inflammation via Computational Modeling. Front Physiol (2012) 0.93
Insights into the Role of Chemokines, Damage-Associated Molecular Patterns, and Lymphocyte-Derived Mediators from Computational Models of Trauma-Induced Inflammation. Antioxid Redox Signal (2015) 0.87
Sepsis: from pattern to mechanism and back. Crit Rev Biomed Eng (2012) 0.87
Global sensitivity analysis of a mathematical model of acute inflammation identifies nonlinear dependence of cumulative tissue damage on host interleukin-6 responses. J Theor Biol (2014) 0.83
Fixed volume or fixed pressure: a murine model of hemorrhagic shock. J Vis Exp (2011) 0.83
Pharmacokinetic/pharmacodynamic modeling in inflammation. Crit Rev Biomed Eng (2012) 0.81
A mathematical model of intrahost pneumococcal pneumonia infection dynamics in murine strains. J Theor Biol (2014) 0.81
Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges. J R Soc Interface (2010) 0.80
Combined in silico, in vivo, and in vitro studies shed insights into the acute inflammatory response in middle-aged mice. PLoS One (2013) 0.79
Inflammation Following Traumatic Brain Injury in Humans: Insights from Data-Driven and Mechanistic Models into Survival and Death. Front Pharmacol (2016) 0.77
Computational modelling of the inflammatory response in trauma, sepsis and wound healing: implications for modelling resilience. Interface Focus (2014) 0.75
Systems biology: a brief overview. Science (2002) 14.69
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem (2003) 8.34
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86
Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med (2002) 5.70
HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J Biol Chem (2002) 4.03
Danger signals: SOS to the immune system. Curr Opin Immunol (2001) 3.91
Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol (2001) 3.76
Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity (1996) 3.33
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol (2002) 3.32
Recognition and plasma clearance of endotoxin by scavenger receptors. Nature (1991) 3.00
How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol (2003) 2.83
CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med (1989) 2.35
Endotoxemia and bacteremia during hemorrhagic shock. The link between trauma and sepsis? Ann Surg (1988) 1.90
Neurobiology of the stress response: contribution of the sympathetic nervous system to the neuroimmune axis in traumatic injury. Shock (2005) 1.85
Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol (2000) 1.84
The acute inflammatory response in diverse shock states. Shock (2005) 1.83
In silico design of clinical trials: a method coming of age. Crit Care Med (2004) 1.78
The community of the self. Nature (2002) 1.72
Atmospheric science. Weather forecasting with ensemble methods. Science (2005) 1.70
Agent-based computer simulation and sirs: building a bridge between basic science and clinical trials. Shock (2001) 1.62
The dynamics of acute inflammation. J Theor Biol (2004) 1.60
Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg (2006) 1.57
Mathematical models of the acute inflammatory response. Curr Opin Crit Care (2004) 1.54
Hemorrhagic shock. Curr Probl Surg (1995) 1.53
Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect Dis Clin North Am (1999) 1.43
Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4. Am J Physiol Regul Integr Comp Physiol (2006) 1.40
Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol (2000) 1.37
Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg (2001) 1.37
Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine (1990) 1.30
Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. J Cell Biol (2004) 1.29
In silico models of acute inflammation in animals. Shock (2006) 1.14
Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg (1993) 1.10
Sepsis research in the next millennium: concentrate on the software rather than the hardware. Shock (2002) 1.07
Complex systems analysis: a tool for shock research. Shock (2001) 1.04
Bacterial translocation in trauma patients. J Trauma (1991) 1.02
Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome. Lab Invest (1996) 1.01
Influence of CD14 on ligand interactions between lipopolysaccharide and its receptor complex. J Immunol (2005) 1.01
Alterations in intestinal bacterial flora modulate the systemic cytokine response to hemorrhagic shock. Am J Physiol (1995) 0.99
Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg (1995) 0.98
Hemorrhagic shock in endotoxin-resistant mice: improved survival unrelated to deficient production of tumor necrosis factor. J Trauma (1993) 0.98
Protection against hemorrhagic shock in the cat by human plasma containing endotoxin-specific antibodies. J Surg Res (1981) 0.95
Complexity and non-linearity in shock research: reductionism or synthesis? Shock (2001) 0.95
Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med (1994) 0.94
Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res (2001) 0.92
CD14 expression in injured patients correlates with outcome. Ann Surg (1996) 0.87
Role of CD14 molecules in internalization of Actinobacillus actinomycetemcomitans by macrophages and subsequent induction of apoptosis. Infect Immun (1997) 0.86
The role of bacterial translocation on neutrophil activation during hemorrhagic shock in rats. Shock (2001) 0.83
Antiserum to endotoxin in hemorrhagic shock. J Surg Res (1988) 0.81
A role of neutrophils in the down-regulation of IL-6 and CD14 following hemorrhagic shock. Shock (1998) 0.81
Significance of translocation/endotoxin in the development of systemic sepsis following trauma and/or haemorrhage. Prog Clin Biol Res (1995) 0.79
Role of the intestinal flora in major trauma. J Infect Dis (1973) 0.77
Relationship of critical uptake volume to energy production and endotoxemia in late hemorrhagic shock. Am J Surg (1975) 0.77
The relationship of circulating endogenous endotoxin to hemorrhagic shock in the baboon. Ann Surg (1974) 0.77
Endogenous endotoxemia during hemorrhagic shock in the subhuman primate. Surg Forum (1972) 0.76
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med (2003) 28.68
Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med (2003) 10.39
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A (2003) 7.14
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA (2009) 6.91
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86
A genomic storm in critically injured humans. J Exp Med (2011) 6.67
Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry (2005) 6.27
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65
The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med (2004) 5.23
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg (2012) 4.70
Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res (2011) 4.22
Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA (2002) 4.09
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med (2003) 4.04
HMGB1: endogenous danger signaling. Mol Med (2008) 4.02
HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med (2007) 3.72
Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A (2002) 3.68
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry (2004) 3.59
Physical health monitoring of patients with schizophrenia. Am J Psychiatry (2004) 3.54
A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant (2010) 3.45
Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect? Arch Gen Psychiatry (2007) 3.26
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry (2003) 3.18
Pneumonia: still the old man's friend? Arch Intern Med (2003) 3.12
Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med (2002) 3.02
Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms? J Clin Psychopharmacol (2007) 2.99
Conditional outlier detection for clinical alerting. AMIA Annu Symp Proc (2010) 2.99
HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology (2002) 2.95
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol (2009) 2.88
What does the PANSS mean? Schizophr Res (2005) 2.86
Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study. Am J Psychiatry (2014) 2.81
Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. Proc Natl Acad Sci U S A (2007) 2.81
Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol (2005) 2.78
Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet (2004) 2.71
Critical care medicine training and certification for emergency physicians. Ann Emerg Med (2005) 2.67
Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock (2006) 2.61
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020. J Clin Oncol (2006) 2.60
Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC). Am J Psychiatry (2010) 2.57
Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided? J Clin Psychiatry (2013) 2.50
Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma (2009) 2.49
Clinical implications of Brief Psychiatric Rating Scale scores. Br J Psychiatry (2005) 2.38
Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int (2009) 2.35
Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion. J Trauma Acute Care Surg (2012) 2.32
Growth of intensive care unit resource use and its estimated cost in Medicare. Crit Care Med (2008) 2.31
Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med (2003) 2.30
Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials. Schizophr Bull (2012) 2.30
Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med (2006) 2.27
Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med (2006) 2.27
Perceptions of safety culture vary across the intensive care units of a single institution. Crit Care Med (2007) 2.24
Translational systems biology of inflammation. PLoS Comput Biol (2008) 2.15
An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma (2008) 2.15
The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry (2003) 2.15
Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med (2003) 2.15
Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol (2007) 2.12
Critical care medicine training and certification for emergency physicians. Crit Care Med (2005) 2.12
Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med (2005) 2.11
Outlier detection for patient monitoring and alerting. J Biomed Inform (2012) 2.10
A comparison of critical care research funding and the financial burden of critical illness in the United States. Crit Care Med (2012) 2.07
Benchmarking outcomes in the critically injured trauma patient and the effect of implementing standard operating procedures. Ann Surg (2012) 2.07
Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol (2006) 2.06
Targeting mitochondria. Acc Chem Res (2008) 2.03
Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol (2007) 2.02
Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med (2003) 2.01
Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism. Hepatology (2009) 1.98
Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials. Schizophr Bull (2008) 1.93
Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics (2003) 1.92
High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab (2011) 1.89
Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis. Crit Care Med (2004) 1.88
Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int (2011) 1.87
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132. Ann Surg Oncol (2011) 1.86
Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun (2002) 1.85
The acute inflammatory response in diverse shock states. Shock (2005) 1.83
Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2012) 1.82
Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study. Biol Psychiatry (2005) 1.80
Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria. Am J Respir Crit Care Med (2002) 1.78
In silico design of clinical trials: a method coming of age. Crit Care Med (2004) 1.78
Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant (2009) 1.78
Tardive dyskinesia circa 2006. Am J Psychiatry (2006) 1.78
Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies. J Clin Psychiatry (2013) 1.76
Nitric oxide and wound repair: role of cytokines? Nitric Oxide (2002) 1.73
Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial. Crit Care Med (2004) 1.73